16,900 Shares in MiMedx Group, Inc (NASDAQ:MDXG) Purchased by Allianz Asset Management GmbH

Allianz Asset Management GmbH purchased a new stake in shares of MiMedx Group, Inc (NASDAQ:MDXG) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 16,900 shares of the company’s stock, valued at approximately $128,000.

A number of other large investors have also added to or reduced their stakes in MDXG. Isthmus Partners LLC grew its holdings in shares of MiMedx Group by 1.1% in the first quarter. Isthmus Partners LLC now owns 310,262 shares of the company’s stock valued at $2,358,000 after purchasing an additional 3,455 shares in the last quarter. New York State Common Retirement Fund lifted its position in MiMedx Group by 51.8% during the first quarter. New York State Common Retirement Fund now owns 87,781 shares of the company’s stock valued at $667,000 after purchasing an additional 29,941 shares during the last quarter. Alps Advisors Inc. purchased a new position in shares of MiMedx Group in the 1st quarter worth $340,000. OneDigital Investment Advisors LLC increased its holdings in shares of MiMedx Group by 3.9% in the 1st quarter. OneDigital Investment Advisors LLC now owns 55,157 shares of the company’s stock worth $419,000 after buying an additional 2,056 shares during the last quarter. Finally, HighMark Wealth Management LLC increased its holdings in shares of MiMedx Group by 1,333.3% in the 1st quarter. HighMark Wealth Management LLC now owns 43,000 shares of the company’s stock worth $327,000 after buying an additional 40,000 shares during the last quarter. Institutional investors own 79.15% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on MDXG shares. Wall Street Zen upgraded MiMedx Group from a “hold” rating to a “strong-buy” rating in a research report on Saturday. Cantor Fitzgerald raised their price objective on MiMedx Group from $11.00 to $12.00 and gave the company an “overweight” rating in a research note on Thursday, July 31st.

MiMedx Group Stock Down 0.1%

NASDAQ MDXG opened at $7.15 on Tuesday. The company has a quick ratio of 3.90, a current ratio of 4.39 and a debt-to-equity ratio of 0.08. MiMedx Group, Inc has a 52 week low of $5.47 and a 52 week high of $10.14. The firm has a market capitalization of $1.06 billion, a price-to-earnings ratio of 34.05 and a beta of 1.79. The company has a fifty day moving average of $6.45 and a two-hundred day moving average of $7.23.

MiMedx Group (NASDAQ:MDXG) last released its earnings results on Wednesday, July 30th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.04. MiMedx Group had a net margin of 8.84% and a return on equity of 23.03%. The firm had revenue of $98.61 million during the quarter, compared to analyst estimates of $90.79 million. On average, analysts predict that MiMedx Group, Inc will post 0.3 earnings per share for the current year.

About MiMedx Group

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.